Prof. Rajiv Sarin trained in Clinical Oncology & Radiation Oncology at the Tata Memorial Hospital (TMH) & the Royal Marsden Hospital London and Cancer Genetics at University of Utah, Salt Lake City. Prior to the current assignment as the Director of the institute since 2005, he was the lead investigator in Breast Cancer & Brain Tumour Radiotherapy & Cancer Genetics at TMH. Starting from the 1^st registry of Hereditary Cancer in the country in 1996, he developed a model Cancer Genetics Unit comprising of a Cancer Genetics Clinic in 2003 & Genetics Lab (SARIN Lab) in 2007. Prof. Sarin is the lead investigator in the International Cancer Genome Consortium (ICGC) India project for Oral Cancers and also the ICMR Centre for Advanced Research in Cancer Genetics & Genomics. He serves as the member of two International working groups of the ICGC.

Prof. Sarin is a member of various expert committees & task forces for cancer research and cancer management & he drafted the base paper for research in the Indian National Cancer Control Programme. He is the Executive Editor of the Journal of Cancer Research & Therapeutics which is the leading Indexed Cancer Journal from developing World. He is also serves on the Editorial board of leading cancer journals like Lancet Oncology, Molecular Oncology, Radiotherapy Oncology, Cancer Biomarkers, Mammology etc. Has over 75 peer reviewed publications and editorials in leading journals on various issues of cancer, health care, Cancer genetics, radiobiology etc.